These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2551338)

  • 1. Possible abuse potential of the NMDA antagonist MK-801.
    Corbett D
    Behav Brain Res; 1989 Sep; 34(3):239-46. PubMed ID: 2551338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.
    Hillhouse TM; Porter JH; Negus SS
    Psychopharmacology (Berl); 2014 Jul; 231(13):2705-16. PubMed ID: 24522331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ; Rose IC
    Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The topography of MK-801-induced locomotor patterns in rats.
    Ford LM; Norman AB; Sanberg PR
    Physiol Behav; 1989 Oct; 46(4):755-8. PubMed ID: 2557649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M; Cho AK; Nabeshima T
    Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
    Schmidt WJ; Bubser M
    Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine-like discriminative stimulus properties of MK-801 in rats.
    Willetts J; Balster RL
    Eur J Pharmacol; 1988 Jan; 146(1):167-9. PubMed ID: 3280331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.
    Wong EH; Knight AR; Woodruff GN
    J Neurochem; 1988 Jan; 50(1):274-81. PubMed ID: 2826686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist.
    Criswell HE; Mueller RA; Breese GR
    Brain Res; 1990 Apr; 512(2):284-90. PubMed ID: 2162235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors.
    Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL
    Neuropharmacology; 1990 Mar; 29(3):225-30. PubMed ID: 2158000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage.
    Papagapiou MP; Auer RN
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):270-6. PubMed ID: 2154510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.